Sapient Capital LLC Has $908,000 Stake in Colgate-Palmolive (NYSE:CL)

Sapient Capital LLC raised its position in shares of Colgate-Palmolive (NYSE:CL) by 1.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,990 shares of the company’s stock after acquiring an additional 157 shares during the period. Sapient Capital LLC’s holdings in Colgate-Palmolive were worth $908,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Arlington Trust Co LLC grew its stake in shares of Colgate-Palmolive by 29.5% during the fourth quarter. Arlington Trust Co LLC now owns 3,814 shares of the company’s stock valued at $347,000 after purchasing an additional 868 shares during the last quarter. Equitable Trust Co. bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $212,000. Soltis Investment Advisors LLC grew its stake in shares of Colgate-Palmolive by 374.4% during the fourth quarter. Soltis Investment Advisors LLC now owns 10,745 shares of the company’s stock valued at $977,000 after purchasing an additional 8,480 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $87,000. Finally, Savant Capital LLC grew its stake in shares of Colgate-Palmolive by 4.0% during the fourth quarter. Savant Capital LLC now owns 42,856 shares of the company’s stock valued at $3,896,000 after purchasing an additional 1,631 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Up 1.6 %

Shares of NYSE CL opened at $87.35 on Wednesday. The company’s fifty day moving average is $90.14 and its 200-day moving average is $96.69. The stock has a market cap of $71.37 billion, a price-to-earnings ratio of 24.82, a P/E/G ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business earned $0.87 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive’s payout ratio is 56.82%.

Analyst Ratings Changes

Several research firms have recently commented on CL. Barclays decreased their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. UBS Group reduced their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.